De-Risking Drug Development With Organ-On-A-Chip Contract Research Services

The enactment of the FDA Modernization Act 2.0 signals a pivotal moment for the pharmaceutical industry, heralding the adoption of alternative research models such as Organ-Chips and marking a shift toward a more human-centric approach to drug development. Amidst this transformation, there's a growing interest in how researchers can integrate these advanced in vitro tools into their own studies to enhance decision-making throughout the drug development process.

Engaging with Organ-Chip service providers, like Emulate, offers a straightforward entry point into leveraging this technology. Through collaboration with Emulate's team of expert scientists, equipped with extensive experience in tailored experiment design and execution across various validated Organ-Chip models, researchers can access valuable insights into optimizing their drug development strategies.

Watch the webinar below to explore the diverse range of Organ-on-a-Chip services available and learn about our customized approach to study design, backed by data-driven case studies illustrating the impact of Emulate's collaboration on enhancing decision-making in pharmaceutical development.